Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Akoya Biosciences, Inc. (AKYA : NSDQ)

• Company Description    Akoya Biosciences Inc. offers comprehensive single-cell imaging solutions which allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. The company offer distinct solutions, the CODEX(R) and Phenoptics(TM) platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. Akoya Biosciences Inc. is based in MARLBOROUGH, Mass. Number of Employees: 319

• Price / Volume Information    Yesterday's Closing Price: $9.47 Daily Weekly Monthly 20 Day Moving Average: 72,853 shares Shares Outstanding: 37.59 (millions) Market Capitalization: $355.97 (millions) Beta: 52 Week High: $23.44 52 Week Low: $8.02 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -11.82% -0.68% 12 Week -12.72% -4.04% Year To Date -38.15% -24.42%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 100 CAMPUS DRIVE 6TH FLOOR - MARLBOROUGH,MA 01762 USA ph: 855-896-8401 fax: - investors@akoyabio.com http://www.akoyabio.com

• General Corporate Information    Officers Brian McKelligon - Chief Executive Officer and President Robert Shepler - Chairman Frederic Pla - Chief Operating Officer Joseph Driscoll - Chief Financial Officer Thomas Raffin - Director Peer Information Akoya Biosciences, Inc. (CORR.) Akoya Biosciences, Inc. (RSPI) Akoya Biosciences, Inc. (CGXP) Akoya Biosciences, Inc. (BGEN) Akoya Biosciences, Inc. (GTBP) Akoya Biosciences, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 00974H104 SIC: 3826 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/09/22 Share - Related Items Shares Outstanding: 37.59 Most Recent Split Date: (:1) Beta: Market Capitalization: $355.97 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.34 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.41 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/09/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.34 Price/Cash Flow: - Price / Sales: 5.97 EPS Growth vs. Year Ago Period: 84.56% vs. Previous Quarter: 6.38% Sales Growth vs. Year Ago Period: 38.34% vs. Previous Quarter: 4.56% ROE 03/31/22 - -39.95 12/31/21 - -47.57 09/30/21 - -67.77 ROA 03/31/22 - -26.29 12/31/21 - -24.62 09/30/21 - -21.00 Current Ratio 03/31/22 - 3.98 12/31/21 - 5.09 09/30/21 - 8.42 Quick Ratio 03/31/22 - 3.63 12/31/21 - 4.76 09/30/21 - 8.07 Operating Margin 03/31/22 - -86.00 12/31/21 - -74.78 09/30/21 - -56.29 Net Margin 03/31/22 - -86.00 12/31/21 - -78.18 09/30/21 - -59.91 Pre-Tax Margin 03/31/22 - -86.18 12/31/21 - -78.44 09/30/21 - -60.01 Book Value 03/31/22 - 2.83 12/31/21 - 3.26 09/30/21 - 3.70 Inventory Turnover 03/31/22 - 2.75 12/31/21 - 3.14 09/30/21 - 3.65 Debt-to-Equity 03/31/22 - 0.31 12/31/21 - 0.27 09/30/21 - 0.24 Debt-to-Capital 03/31/22 - 23.66 12/31/21 - 21.21 09/30/21 - 19.19

Powered by Zacks Investment Research ©